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Conclusion; Urinary 8-isoprostane is elevated in smokers and may provide
a sensitive, specific and noninvasive method for assessment of in vivo lipid
peroxidation. Further studies are indicated to determine whether elevated
8-isoprostane identifies individuals at risk for developing atherosclerosis.
Use of the Internet and World Wide Web for
Dissemination and Collection of Midwest
Pediatric Pacemaker Registry Information
of effort to complete. The prototype system is undergoing alpha testing. For
the prototype stage, all interpretations of clinical records are overread by a
clinical cardiologist prior to transmission to the user.
Conclusions: This system may be beneficial in increasing the level of care
of patients in the rural setting by providing the ECG interpretation expertise
of an experienced cardiologist to rural practitioners on demand, which may
also lead to decreasing the cost of rural health care. In addition, the system
may be modified for applications in other health care domains.
Gerald A. Serwer, Julie Morris. Univ. of Michigan, Ann Arbor, MI
The Midwest Pediatric Pacemaker registry which provides a large data-base
of information concerning pacemaker implantation in children relies upon
printed articles and meeting presentations for dissemination of collected in-
formation and upon member institutions to complete and mail printed forms
for data submission. This process increases the time necessary for data
submission and slows dissemination of pooled data to the pediatric pacing
community. With increasing Internet access by centers involved in pediatric
pacing, and the development of the World Wide Web (WWW), use of the
WWW was explored to evaluate its potential for information dissemination
and acquisition. Hypertext mark-up language (HTML) documents of compos-
ite Registry statistics, patient demographics with initial implantation indica-
tion, and generator implantation and electrode utilization information were
made available on the Internet by publishing it on the WWW. Documents
presented data both in textual and graphical form and were organized by
topic on different pages to allow selective access directly the data needed.
The graphs presented can be downloaded in GIF format. Use of the easily
prepared HTML documents allows for frequent updating of information with
rapid access by centers involved in pediatric pacing. In addition utilizing the
forms capability of WWW browsers, Pacemaker Registry information can be
submitted on-line The form page is displayed and the information directly
entered. Information entry is accomplished byfilling in character fields, check
boxes and free text fields. The form is then automatically sent to the WWW
server which forwards it to the Registry Director for database entry. It is never
stored on the public access WWW server, ensuring patient confidentiality.
For users without a forms capable WWW browser, a file containing the sub-
mission forms is also provided that can be downloaded. Use of the WWW
and Internet provides more rapid dissemination and collection of Registry in-
formation shortening the period between data collection and data review by
centers involved in pediatric pacing which should improve the quality of care
delivered to children requiring permanent pacing. Use of WWW can provide
a rapid means of medical data dissemination and communication.
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P-Value
P ~ 00021.55 ± 022
2.77 ± 0.21
Mean ± SEM
8-Epi-Prostaglandin F2a (8-lsoprostane), a Novel
Marker of Lipid Peroxidation, is Elevated and
Inversely Correlated to Serum Antioxidant
Vitamins in Smokers
8-lsoprostane
Values ~ /.I-g/24 hours
Nonsmokers
Smokers
Emile R. Mohler, Pam McClelland, David R. Hathaway, Peter Reaven. Krannert
Institute of Cardiology, Indiana University, Indianapolis, IN; University of California San
Diego, La Joffa, CA
Oxidative modification of lipoproteins is thought to be an essential event
in atherosclerosis. Current methods of quantifying lipid peroxidation in vivo
are technically difficult andlor nonspecific. A simple, clinically reliable test is
needed to assess an individual's degree of lipid peroxidation which could
be a powerful predictor of cardiovascular disease risk. 8-lsoprostane is a
chemically stable prostanoid resulting from free radical catalyzed peroxida-
tion of arachidonic acid. This molecule is produced by oxidation of low den-
sity lipoprotein and is present in both plasma and urine. To evaluate this novel
marker of in vivo lipid peroxidation, we compared 24 hour urinary levels of
8-isoprostane in healthy smokers (n = 15) and nonsmokers (n = 9) with a
competitive enzyme immunoassay. Serum was also obtained for analysis of
lipid and antioxidant vitamin levels. Smokers were found to have higher lev-
els of urinary 8-isoprostane than nonsmokers and these levels were inversely
correlated with serum beta carotene (P = 0.04, r = -0.44) and vitamin C (P
= 0.01, r = -0.52). No significant differences were detected in lipid profiles
between smokers and nonsmokers.
Risk ratios were estimated for each group using Group 1 as a reference
and were only significantly elevated for Group 4 (2.6 ± 0.3; p < 0.0011. The
findings of this prospective study indicate that high fibrinogen levels are as-
sociated with a greater risk of IHD and that risk is associated with high Lp(a)
levels.
1917-1001
A Telemedicine Arrhythmia Analysis Tool for
Rural Physicians
David A. Tong, Lawrence E. Widman. University of Oklahoma Health Sciences Center,
Oklahoma City, OK
Introduction; Rural health care practitioners are often faced with the task of
interpreting complex heart rhythms. Usually these practitioners do not have
specialized training in cardiology or ECG interpretation and available com-
mercial systems for interpreting 12-lead ECG have been well-documented
to perform rhythm analysis poorly. A computer-based tool is being devel-
oped in our laboratory that will provide rural health care practitioners with an
automated system for interpreting complex arrhythmias.
Methods: A prototype system was developed using resources readily
available in on the Internet: NCSA Mosaic, a hypermedia document browser;
NCSA Collage, an interactive distributed white-board system; and GNU
GhostscriptiGhostview, a PostScript language interpretation system. The
prototype was created by modifying and integrating the functionality of the
individual systems into a single, easy to use system. The prototype was de-
veloped in C on UNIX workstations using the X display protocol and is based
on the client-server model. The system may be accessed by any computer
on the Internet with X display capability.
On the client side, the system assists the user in scanning an ECG, identi-
fying the waves in the scanned ECG, and transmitting the scanned ECG and
annotations to the server. On the server side, the system analyzes the anno-
tations using an knowledge-based rhythm analysis system being developed
in our laboratory. The system produces a PostScript file containing the in-
terpretation(s) and accompanying ladder diagrams and a case-specific help
file containing detailed descriptions and therapeutic indications. These files
are transmitted back to the user's computer and displayed to the user by the
client-side of the system. The design of the system provides for an "on-line,"
interactive consultation with a cardiologist.
Results: Development of the prototype system required 2.5 man-months
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1710-1 1 Changing Perspectives in Vein Graft Angioplasty
John S. Douglas Jr, William S. Weintraub, Spencer B. King III. Emory University
School ofMedicine, Atfanta, GA
In recent years angioplasty has been used increasingly in patients with more
severe disease. Technological improvements, including new interventional
devices has also changed the practice of interventional cardiology. To deter-
mine the impact of these changes on intervention in vein grafts, the results
of intervention in 1284 patients undergoing procedures between 1980 and
1993 were reviewed. Results (mean or %):
Year 80-2 83-4 85-6 87--8 89-0 91-2 93 P
n 52 112 99 191 299 359 172
Age 55 57 60 62 62 64 65 <0.0001
3 VDILM 46% 29% 42% 62% 53% 67% 69% <0.0001
EF 63 60 53 54 50 51 49 <0.0001
PriorMI 39% 49% 52% 62% 63% 56% 60% 0.009
New Dev a a a 1% 11% 35% 27% <0.0001
%DS Pre 80 78 78 77 77 80 81 0003
%DS Post 33 27 27 29 26 17 17 <0.0001
Ang Succ 81% 89% 84% 85% 88% 96% 94% <0.0001
OMI 1,9% 2.7% 3.0% 0.5% 2.3% 0.8% 1.8% NS
CABG 3.8% 1.8% 4.0% 2.6% 3.3% 0.8% 2.4% NS
Death a a 3.0% 1.0% 1.3% 1.4% 1.2% NS
Vein graft interventions have become more common. Despite an older and
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more severely diseased population with more prior myocardial infarctions
(Mil, lower ejection fractions (H) and more 3 vessel or left main disease
(3 VD/LM). the angiographic success (Ang Succ) and residual stenosis (%DS
Post) have improved, without increased complications of a wave myocardial
infarction (0 MIl. emergency coronary bypass surgery (CABG) or in hospital
death (Death), In recent years new interventional devices (New Dev) have
been used in a large minority of patients, contributing to the improved re-
sults.
All comparisons between the 2 groups were not statistically significant.
In Conclusion: After S placement. irrespective of SVG age, 1) acute and late
angiographic results and restenosis rates were similar and 2) clinical results
(i.e. procedural success, major complications, target lesion revascularization
and 12-months event free survival) were comparable. Thus, unlike PTCA, in
appropriate SVG lesions, the favorable early and 12-month clinical outcomes
after S therapy are not diminished by advanced SVG age.
2:30
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1710-21 Coronary Stents Versus Balloon Angioplasty for
Aorto-Coronary Saphenous Vein Bypass Graft
Disease: Interim Results of a Randomized Trial
Fibrotic Ectatic p
Reference EEM area (mm2) 19.8 ± 7.3 18.6 ± 5.9 NS
Reference lumen area (mm2) 106 ± 4.4 106 ± 3.6 NS
Reference plaque area (mm2) 106 ± 100 8.0 ± 3.8 0.0052
Lesion site pre-intervention
Angiographic % diameter stenosis 63 ± 20 60 ± 22 NS
EEM area (mm 2) 16.1 ± 6.8 258 ± 10.6 <00001
Lumen area (mm2) 2.6 ± 2.2 3.6 ± 2.7 00016
Plaque + media area (mm2) 13.5 ± 6.4 21.9 ± 8.4 <00001
Arc of calcium n 61 ± 83 26 ± 54 0.001
Lesion/Reference plaque area 1.6 ± 0.7 3.1 ± 1.3 <0.0001
Lesion site post-intervention
Angiographic %diameter stenosis 17 ± 17 12 ± 19 0.0903
Lumen area (mm2) 67 ± 25 85 ± 2.9 0.0001
Follow-up angiographic %diameter stenosis 54 ± 33 35 ± 32 0.0329
16% of "fibrotic" had a lesion plaque area < reference. Importantly, (1)
post-intervention minimum lumen areas were significantly smaller in fibrotic
lesions, and (2) at follow-up the angiographic % diameter stenosis was signif-
icantly larger in fibrotic lesions. We Conclude: 40% of vein graft lesions may
be classified as "fibrotic". "Fibrotic" lesions have a decreased plaque bur-
den and more lesion-associated calcium. Lumen compromise results from
vessel retraction (?periadventitial fibrosis). In these lesions it may be more
difficult to achieve optimal final lumen dimensions resulting in more frequent
restenosis.
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1710-41 The Dimorphic Pathology of Vein Graft Lesions
Effects Acute Procedural and Late Angiographic
Outcomes
Gary S. Mintz, Jeffrey J. Popma, Augusto D. Pichard, Kenneth M. Kent, Lowell
F. Satler, S. Chiu Wong, Mun K. Hong, Jack A. Painter, Julie Mackenzie, Martin
B. Leon. Washington Hospital Center. Washington, DC
In an attempt to understand better the pathology and results of transcatheter
therapy of vein graft lesions, we performed intravascular ultrasound and
quantitative angiographic analysis of 244 nonostial vein graft lesions. Pre-
and post-intervention lesion site external elastic membrane (EEM), lumen,
and plaque cross-sectional areas, calcium, and % cross-sectional narrowing
(plaque/EEM area) were compared to a proximal reference site (most normal
looking cross-section within 10 mm proximal to the lesion). Lesions were di-
vided into two groups: 98 lesions with lesion EEM ::; reference ("fibrotic");
146 lesions with lesion EEM > reference ("ectatic"). There was no difference
in vein graft age, lesion length, or history of restenosis between the two
groups.
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1710-5\ Progressive Deterioration in Late (2-Year) Clinical
Outcomes After Stent Implantation in Saphenous
Vein Grafts: The Multicenter JJIS Experience
Michael H. Sketch, Jr., S. Chiu Wong, Ya Chien Chuang, Harry R. Phillips,
Richard Heuser, Michael Savage, Richard S. Stack, Donald S. Bairn, Richard
A. Schatz, Martin B. Leon, JJIS Stent Investigators. Duke University Medical Center.
Durham, N. C.
Late clinical follow-up (after I-year) in patients treated with native coronary
stents demonstrates no further clinical events (death or MI) and rare delayed
target lesion revascularization (TLR = repeat PTCA or CABG). To examine
the long-term effects of stent placement in saphenous vein grafts (SVG), we
evaluated all follow-up clinical data in 661 consecutive patients (775 SVG le-
sionsl from the JJIS multicenter registry (17 sites). Baseline demographics
were pertinent for a high incidence of unstable angina (72%), heart failure
(22%). and high surgical risk status (49%). The mean SVG age was 9 ± 4
years, and the mean ejection fraction was 49 ± 14%. Overall procedure suc-
cess «50% residual stenosis without in-hospital death. MI, or CABG) was
92%, and subacute thrombosis was documented in 9 patients (14%).
SVG Age >4 years
34±0.6[6 ± 101
2.3 ± 1.3133 ± 361
28.7
97.0
1.7/04/09
54/9.5
77.0
SVG Age <4 years
33±0.717 ±121
2.1 ± 1.3142 ± 361
35.6
971
14/0/14
57/143
730
Angiographic results PICA Stent Clinical Events 1%) PICA Stent
Vessel diameter (mm) 3.21 3.18 Death 3.3 59
Baseline mid (mm) 0.98 093 O-wave MI 1.7 1.5
Final mid (mm) 2.12 2.85' Bypass Surgery 67 0"
Final % diam stenosis 33 12' Closure: S24 hrs 33 2.9
Procedure success (%) 85 96*>1: >24 hrs 1.7 0
, p < 0.01," p < 0.05 vs PICA
One or more major clinical events occurred in 11.7% of PTCA patients
vs 5.9% of Stent patients (p = ns). Crossover from assigned to alternative
therapy (including bypass surgery) was 13.3% for the PTCA group vs 1.5%
for the Stent group (p < 0.01). In conclusion, the preliminary findings of this
prospective trial indicate: (1) Elective stent placement in de novo saphenous
vein bypass graft lesions achieves a superior initial angiographic result com-
pared to balloon angioplasty; (2) Stents confer a salutary effect on early clini-
cal events with less frequent need for alterna1e therapies including coronary
bypass surgery.
Michael Savage, John Douglas, David Fischman, Sarah Fenton, Spencer King,
Carl Pepine, Steven Bailey, Paul Overlie, Jeffrey Werner, Martin Leon,
Richard Heuser, Jeffrey Brinker, Maurice Buchbinder, Richard Smalling,
David Snead, Randal Rake, Sharon Gebhardt, Richard Kerensky,
Thomas Wargovich, Sheldon Goldberg, SAVED Trial Investigators. Jefferson
Medical College, Philadelphia, PA
The purpose of this interim analysis of the SAVED Restenosis Trial was to
assess the acute results of balloon angioplasty (PTCA) and elective Palmaz-
Schatz coronary stent placement in the treatment of de novo venous bypass
graft lesions. As of August I, 1994, 128 patients (60 PTCA, 68 Stent) have
been enrolled at 13 centers. Baseline demographics were similar in both
groups. Mean graft ages in the PTCA and Stent groups were 9.8 ± 4.2 vs 9.7
± 4.5 years (p = ns). Initial angiographic results by core laboratory analysis
and clinical events from 0 to 30 days were as follows:
Angiographic Findings:
Final MLD (mm) [% stenosisl
Follow-up MLD 1% stenosis]
Restenosis (>50% stenosis)
Clinical Results: 1%)
Procedural success
In hospital deathlO-wave MIICABG
Follow-up target lesion CABG/PICA
12·month event free survival
1710-31 Stent Placement is Safe and Effective in the
Treatment of Older (>4 Years) Saphenous Vein Graft
Lesions
S. Chiu Wong, Ya Chien Chuang, Mun K. Hong, Augusto D. Pichard, Lowell
F. Saller, Kenneth M. Kent, Kathi Donovan, Donald S. Baim, Richard A. Schatz,
Martin B. Leon. Washington Hospital Center. Washington, DC
Conventional balloon angioplasty (PTCA) in older (>4 years) saphenous vein
grafts (SVGs) is associated with reduced procedural success and less favor-
able late clinical outcomes. To determine if stent (S) implantation neutral-
izes the adverse effects of SVG age on clinical events, we analyzed the early
and late results of 617 consecutive pts from the Palmaz-Schatz SVG S reg-
istry. In 69 pts (13.3%), SVG age was ::;4 (mean 2.1 ± 1.3) years and in 448
pts (86.7%), SVG age was >4 (mean 9.9 ± 3.5) years. There were no sig-
nificant differences in pt demographics and lesion characteristics between
the 2 groups. Procedural success was defined as successful S deployment
with <50% residual stenosis without major complications (death/ a-wave
Mil CABG). FOllow-up angiograms were obtained in 63% of pts with SVG
SO 4 years and in 60% of pts with SVG > 4 years. MLD = minimal lumen
diameter.
